Option Care(US:OPCH)2025-02-26 11:56Revenue Projections - For Q4 2024, Option Care Health expects net revenue of approximately $1.34 billion to $1.35 billion, representing a growth of approximately 19.2% to 20.1% over Q4 2023[4] - For the full year 2024, net revenue is expected to be approximately $4.99 billion to $5.00 billion, indicating a growth of approximately 16.0% to 16.2% compared to the prior year[4] - For full year 2025, Option Care Health expects net revenue of $5.2 billion to $5.4 billion, with adjusted EBITDA of $445 million to $465 million[11] EBITDA and Income Projections - Adjusted EBITDA for Q4 2024 is projected to be approximately $118.7 million to $121.7 million, reflecting a 6.4% to 9.1% increase over Q4 2023[4] - Adjusted net income for full year 2024 is projected to be approximately $268.3 million to $274.1 million, with adjusted diluted earnings per share of $1.55 to $1.59[4] Cash Flow and Financial Guidance - The company anticipates cash flow from operations of at least $300 million for the full year 2024[4] - The company will provide further financial guidance for 2025 during its Q4 earnings call scheduled for February 26, 2025[8] Stock Repurchase Program - The company has authorized a new $500 million stock repurchase program, following the completion of a previous $90 million program[6] Impact of Pricing Adjustments - A negative gross profit impact of approximately $60 million to $70 million is expected for 2025 due to Stelara pricing adjustments[5] Upcoming Events - Option Care Health will participate in the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025[7]